Bio-Rad Laboratories, Inc. (BIO)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 11:44AM EDT. Market open.
| Previous close | 278.21 |
| Open | 277.88 |
| Bid | 274.24 x 1200 |
| Ask | 275.10 x 3000 |
| Day's range | 272.45 - 277.27 |
| 52-week range | 261.59 - 473.50 |
| Volume | |
| Avg. volume | 208,759 |
| Market cap | 7.833B |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -21.81 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 409.80 |
ZacksNew Strong Sell Stocks for April 19th
ATNI, ABR and BIO have been added to the Zacks Rank #5 (Strong Sell) List on April 19, 2023.
ZacksBio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.
Business WireBio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
HERCULES, Calif., April 18, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
© 2024 Yahoo. All rights reserved.